Journal of Applied Physiology Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


J Appl Physiol (May 7, 2009). doi:10.1152/japplphysiol.00040.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
107/1/144    most recent
00040.2009v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodman, C. A.
Right arrow Articles by Hayes, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman, C. A.
Right arrow Articles by Hayes, A.
Submitted on January 15, 2009
Revised on April 27, 2009
Accepted on May 7, 2009

Taurine supplementation increases skeletal muscle force production and protects muscle function during and after high frequency in vitro stimulation

Craig A. Goodman1*, Deanna Horvath2, Christos Stathis2, Trevor Mori3, Kevin Croft3, Robyn M. Murphy4, and Alan Hayes2

1 The University of Melbourne
2 Victoria University
3 University of Western Australia
4 La Trobe University

* To whom correspondence should be addressed. E-mail: goodmanc{at}unimelb.edu.au.

Recent studies report that depletion and repletion of muscle taurine (Tau) to endogenous levels affects skeletal muscle contractility in vitro. In this study, muscle Tau content was raised above endogenous levels by supplementing male Sprague Dawley rats with 2.5% (w/v) Tau in drinking water for 2 weeks after which EDL muscles examined for in vitro contractile properties, fatigue resistance and recovery from fatigue after two different high frequency stimulation bouts was examined. Tau supplementation increased muscle Tau content by ~40%, isometric twitch force by 19%, shifted the force-frequency relationship upwards and to the left, increased specific force by 4.2% and and increased muscle calsequestrin protein content by 49%. Force at the end of a 10 s (100Hz) continuous tetanic stimulation was 6% greater than controls, while force at the end of the 3 min intermittent high frequency stimulation bout was significantly higher than controls with a 12% greater area under the force curve. For 1 h after the 10 s continuous stimulation, tetanic force in Tau supplemented muscles remained relatively stable while control muscle force gradually deteriorated. After the 3 min intermittent bout, tetanic force continued to slowly recovery over the next 1 h while control muscle force again began to decline. Tau supplementation attenuated F2-isoprostane production (a sensitive indicator of reactive oxygen species-induced lipid peroxidation) during the 3 min intermittent stimulation bout. Finally, Tau transporter protein expression was not altered by the Tau supplementation. Our results demonstrate that raising Tau content above endogenous levels increases twitch, sub-tetanic and specific force in rat fast twitch skeletal muscle. Also, we demonstrate that raising Tau protects muscle function during high frequency in vitro stimulation and the ensuing recovery period, and helps reduce oxidative stress during prolonged stimulation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1948 by the American Physiological Society.